Cell Research

Papers
(The TQCC of Cell Research is 61. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma173
An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments140
O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an “O-Follow-N” rule137
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2133
Author Corrections: VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex113
Author Correction: The mitochondrial genome encodes abundant small noncoding RNAs109
An exercise infusion benefits brain function106
Endogenous reverse transcriptase and RNase H-mediated antiviral mechanism in embryonic stem cells101
Beyond targeted protein degradation: LD·ATTECs clear cellular lipid droplets99
UHRF1: a novel metabolic guardian restricting AMPK activity97
Cryo-EM structure of the nuclear ring from Xenopus laevis nuclear pore complex93
Somatic mutation accumulation seen through a single-molecule lens93
Structural basis of acyl-CoA transport across the peroxisomal membrane by human ABCD187
Heterogeneity in endothelial cells and widespread venous arterialization during early vascular development in mammals87
Revealing the secret behind Smo cholesterylation85
Integrin αEβ7+ T cells direct intestinal stem cell fate decisions via adhesion signaling82
Nascent RNA m6A modification at the heart of the gene–retrotransposon conflict79
Zipper head mechanism of telomere synthesis by human telomerase79
The reinvention of potato76
Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects75
Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern74
Merging PROTAC and molecular glue for degrading BTK and GSPT1 proteins concurrently72
Neutralizing shapeshifting pericytes enhances glioblastoma therapeutic efficacy69
Structural insights into sphingosine-1-phosphate recognition and ligand selectivity of S1PR3–Gi signaling complexes68
Nuclear translocation of the 4-pass transmembrane protein Tspan863
A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid–liquid phase separation to promote oncogenic YAP signaling62
Novel attempts launched toward universal Sarbecovirus vaccine61
Structural insights into the membrane microdomain organization by SPFH family proteins61
Publisher Correction: Gephyrin: a scaffold that builds a phase at the inhibitory postsynapses61
0.77624106407166